Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Yes, so many roles Ccr5 plays in cancer’s goal

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154115
(Total Views: 399)
Posted On: 07/18/2019 6:50:30 AM
Avatar
Posted By: trding
Re: ohm20 #4987
Yes, so many roles Ccr5 plays in cancer’s goal metastasis. In addition to these below by Pestell, blocking Ccr5 turns MAMs from cancer promoting to cancer killing. I suspect this latest find is yet another new Ccr5 connection we will find.


https://s3.amazonaws.com/content.stockpr.com/...R.full.pdf

Quote:

First, human breast cancer and breast cancer cell lines were shown to express CCR5 with expression patterns that are heterogeneous within the tumor, and higher cytoplasmic CCR5 staining correlated with poor prognosis. Second, the 1668 Cancer Res; 78(7) April 1, 2018
CCR5þ-expressing human breast cancer cells within the tumor initiate tumors in mice that grow approximately 60-fold larger than CCR5 cells. Third, CCR5 antagonists reduced the ability of basal breast cancer cells to metastasize. Fourth, CCR5 expression correlated with the ability of breast cancer cells to form mammospheres, a surrogate assay for tumor-initiating cells. Fifth, functional analysis demonstrated endogenous CCR5 enhanced DNA repair (HDR and SSA) in response to DNA-damaging agents used in chemotherapy for breast cancer and enhanced repair in response to high dose g -irradiation and unbiased gene expression analysis of CCR5þ cells demonstrated enrichment of pathways governing DNA damage and DNA repair. Consequently, CCR5 antagonists substantially enhanced the cell killing of diverse human breast cancer cell lines in response to DNA damage– inducing chemotherapy.



https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243037/

135524544_magpromotef1.jpg
2141343463_magpromote.jpg


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us